Literature DB >> 7206024

Extramedullary plasmacytoma of the larynx.

K Bjelkenkrantz, J Lundgren, J Olofsson.   

Abstract

Extramedullary plasmacytomas, indistinguishable histologically from multiple myeloma, are fairly uncommon tumors, which are most frequently located in the upper airways. However, the larynx is rarely involved. Ten per cent of reported cases have multiple lesions. The patient reported here had a plasmacytoma of the right false vocal cord which was removed by laryngofissure one month after irradiation treatment (50 Gy) since the tumor showed only a slight regression. Tonsillectomy was performed for another plasmacytoma of the left tonsil. The patient has now been followed for seven years, and there has been no evidence of systemic disease.

Entities:  

Mesh:

Year:  1981        PMID: 7206024

Source DB:  PubMed          Journal:  J Otolaryngol        ISSN: 0381-6605


  4 in total

1.  Extramedullary plasmacytoma of the larynx.

Authors:  José Antônio Pinto; Thiago Branco Sônego; Marina Spadari Artico; Carolina de Farias Aires Leal; Silvana Bellotto
Journal:  Int Arch Otorhinolaryngol       Date:  2012-07

2.  Extramedullary plasmacytoma of the larynx: Literature review and report of a case who subsequently developed acute myeloid leukemia.

Authors:  Shenglei Ge; Ganghua Zhu; Yan Yi
Journal:  Oncol Lett       Date:  2018-06-19       Impact factor: 2.967

3.  Rare Differential Diagnosis of Dyspnea: Extramedullary Plasmocytoma (EMP) of the Larynx-Case Report and Review of the Latest Literature of Laryngeal EMP and Laryngeal Involvement of Multiple Myeloma.

Authors:  Kim Vanessa Steinke; Barbara Karoline Schneider; Hans Jürgen Welkoborsky
Journal:  Case Rep Otolaryngol       Date:  2019-04-17

4.  Solitary Extramedullary Plasmacytoma of the Larynx and Secondary Laryngeal Involvement in Plasma Cell Myeloma: Single-Centre Retrospective Analysis and Systematic Literature Review.

Authors:  Elżbieta Szczepanek; Joanna Drozd-Sokołowska; Jacek Sokołowski; Anna Rzepakowska; Arkadiusz Moskwa; Jakub Pachla; Jakub Grzybowski; Katarzyna Woźnica; Kazimierz Niemczyk; Krzysztof Jamroziak
Journal:  J Clin Med       Date:  2022-07-28       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.